JP2018527292A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527292A5
JP2018527292A5 JP2017565192A JP2017565192A JP2018527292A5 JP 2018527292 A5 JP2018527292 A5 JP 2018527292A5 JP 2017565192 A JP2017565192 A JP 2017565192A JP 2017565192 A JP2017565192 A JP 2017565192A JP 2018527292 A5 JP2018527292 A5 JP 2018527292A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
alkyl
compound according
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017565192A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527292A (ja
JP6948708B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/038223 external-priority patent/WO2016205738A2/en
Publication of JP2018527292A publication Critical patent/JP2018527292A/ja
Publication of JP2018527292A5 publication Critical patent/JP2018527292A5/ja
Application granted granted Critical
Publication of JP6948708B2 publication Critical patent/JP6948708B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017565192A 2015-06-19 2016-06-17 薬物制御放出のための送達系 Active JP6948708B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562182219P 2015-06-19 2015-06-19
US62/182,219 2015-06-19
US201562261213P 2015-11-30 2015-11-30
US62/261,213 2015-11-30
US201562261563P 2015-12-01 2015-12-01
US62/261,563 2015-12-01
PCT/US2016/038223 WO2016205738A2 (en) 2015-06-19 2016-06-17 Delivery systems for controlled drug release

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020152004A Division JP2021001185A (ja) 2015-06-19 2020-09-10 薬物制御放出のための送達系

Publications (3)

Publication Number Publication Date
JP2018527292A JP2018527292A (ja) 2018-09-20
JP2018527292A5 true JP2018527292A5 (cg-RX-API-DMAC7.html) 2019-07-18
JP6948708B2 JP6948708B2 (ja) 2021-10-13

Family

ID=57546445

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017565192A Active JP6948708B2 (ja) 2015-06-19 2016-06-17 薬物制御放出のための送達系
JP2020152004A Withdrawn JP2021001185A (ja) 2015-06-19 2020-09-10 薬物制御放出のための送達系
JP2023004453A Active JP7595098B2 (ja) 2015-06-19 2023-01-16 薬物制御放出のための送達系

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020152004A Withdrawn JP2021001185A (ja) 2015-06-19 2020-09-10 薬物制御放出のための送達系
JP2023004453A Active JP7595098B2 (ja) 2015-06-19 2023-01-16 薬物制御放出のための送達系

Country Status (17)

Country Link
US (2) US11384104B2 (cg-RX-API-DMAC7.html)
EP (2) EP3310800B1 (cg-RX-API-DMAC7.html)
JP (3) JP6948708B2 (cg-RX-API-DMAC7.html)
KR (1) KR102905519B1 (cg-RX-API-DMAC7.html)
CN (2) CN107922457B (cg-RX-API-DMAC7.html)
AU (1) AU2016279051B2 (cg-RX-API-DMAC7.html)
CA (1) CA2989963A1 (cg-RX-API-DMAC7.html)
DK (1) DK3310800T3 (cg-RX-API-DMAC7.html)
ES (1) ES2909486T3 (cg-RX-API-DMAC7.html)
IL (1) IL256371B (cg-RX-API-DMAC7.html)
MA (1) MA45472A (cg-RX-API-DMAC7.html)
MX (1) MX386808B (cg-RX-API-DMAC7.html)
NZ (1) NZ738229A (cg-RX-API-DMAC7.html)
PT (1) PT3310800T (cg-RX-API-DMAC7.html)
RU (1) RU2748992C2 (cg-RX-API-DMAC7.html)
WO (1) WO2016205738A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201708234B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106279352B (zh) 2015-05-29 2020-05-22 上海新理念生物医药科技有限公司 海兔毒素10的衍生物及其应用
CA3020348A1 (en) * 2016-04-11 2017-10-19 3R Valo, S.E.C. Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents
US10111966B2 (en) 2016-06-17 2018-10-30 Magenta Therapeutics, Inc. Methods for the depletion of CD117+ cells
SG11201906319XA (en) 2017-01-20 2019-08-27 Magenta Therapeutics Inc Compositions and methods for the depletion of cd137+ cells
EP3617221A4 (en) * 2017-04-19 2021-04-14 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. CYTOTOXIN AND CONJUGATE, USES THEREOF AND MANUFACTURING PROCESSES THEREFORE
US11510982B2 (en) 2017-08-15 2022-11-29 Nantcell, Inc. HaNK cetuximab combinations and methods
BR112020009836A2 (pt) * 2017-11-30 2020-10-13 Centurion Biopharma Corporation pró-drogas de ligação a albumina de derivados de auristatina e
IL305268A (en) * 2017-11-30 2023-10-01 Centurion Biopharma Corp Maytansinoid-based drug delivery systems
CN119219654A (zh) 2017-12-15 2024-12-31 四川科伦博泰生物医药股份有限公司 生物活性物偶联物及其制备方法和用途
CN111447939B (zh) * 2018-01-30 2024-07-12 四川科伦博泰生物医药股份有限公司 制备偶联物的方法
CN113952464B (zh) * 2018-03-06 2024-10-15 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其应用
CN118414339A (zh) * 2021-12-16 2024-07-30 迈威(上海)生物科技股份有限公司 一种喜树碱类化合物及其偶联物
KR20250079213A (ko) 2022-10-09 2025-06-04 라노바 메디신즈 리미티드 화합물, 조성물 및 방법

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125704A (en) 1977-09-14 1978-11-14 Sri International Phenyl-substituted rubidazone analogs
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
JPH02500329A (ja) 1987-05-21 1990-02-08 クリエイテイブ・バイオマリキユールズ・インコーポレーテツド ターゲット化多機能蛋白質
US4966999A (en) * 1988-06-07 1990-10-30 Cytogen Corporation Radiohalogenated compounds for site specific labeling
US5094950A (en) 1988-06-07 1992-03-10 Nihon Medi-Physics Co., Ltd. Diethylenetriamine pentaacetic acid derivatives
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
JP3540315B2 (ja) 1991-09-23 2004-07-07 メディカル リサーチ カウンシル キメラ抗体の製造−組合せアプローチ
DE614989T1 (de) 1993-02-17 1995-09-28 Morphosys Proteinoptimierung Verfahren für in vivo Selektion von Ligandenbindende Proteine.
DE19926154A1 (de) 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6884869B2 (en) 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
AU2004296191B2 (en) 2003-12-04 2010-10-28 Albany Molecular Research, Inc. Vinca derivatives
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
CN101490087B (zh) 2006-05-30 2013-11-06 健泰科生物技术公司 抗体和免疫偶联物及其用途
EP2152312B1 (en) 2007-05-16 2014-12-31 KTB Tumorforschungsgesellschaft mbH Low-viscous anthracycline formulation
EP2289558A1 (en) 2009-08-25 2011-03-02 KTB Tumorforschungsgesellschaft mbH Bisphosphonate-prodrugs
EP2780039B9 (en) 2011-11-17 2018-04-18 Pfizer Inc Cytotoxic peptides and antibody drug conjugates thereof
EP2630971B8 (en) 2012-02-21 2017-12-13 Vergell Medical S.A. Combinations of albumin-based drug delivery systems
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
CN104688740A (zh) 2012-12-21 2015-06-10 百奥泰生物科技(广州)有限公司 类美登素衍生物及其制备方法和用途
US20140221429A1 (en) * 2013-02-04 2014-08-07 Saud Ibrahim Al-Resayes Heterocyclic schiff's bases as novel and new antiglycation agents
FR3005051A1 (fr) 2013-04-25 2014-10-31 Pf Medicament Derives de la dolastatine 10 et d'auristatines
FR3017298B1 (fr) 2014-02-07 2016-03-04 Centre Nat Rech Scient Conjugues et pro-drogues pour le traitement du cancer et de maladies inflammatoires
CA2978340C (en) 2015-03-27 2024-05-28 Regeneron Pharmaceuticals, Inc. Maytansinoid derivatives, conjugates thereof, and methods of use
EP3967227B1 (en) 2015-06-15 2025-07-30 Abbott Diabetes Care Inc. Stabilized lactate responsive enzymes, electrodes and sensors, and methods for making and using the same
IL305268A (en) 2017-11-30 2023-10-01 Centurion Biopharma Corp Maytansinoid-based drug delivery systems
BR112020009836A2 (pt) 2017-11-30 2020-10-13 Centurion Biopharma Corporation pró-drogas de ligação a albumina de derivados de auristatina e

Similar Documents

Publication Publication Date Title
TWI923934B (zh) Bcma 單株抗體及抗體藥物結合物
JP7595098B2 (ja) 薬物制御放出のための送達系
JP2021105007A (ja) 生物活性分子、そのコンジュゲート、及び治療用途
RU2730502C2 (ru) Новые конъюгаты аналогов сс-1065 и бифункциональные линкеры
US20190060473A1 (en) Hsp90 inhibitor drug conjugates
JP7716399B2 (ja) 抗-cd45抗体及びそのコンジュゲート
KR20200083605A (ko) 프로그램가능한 중합체성 약물
TW201116300A (en) DR5 Ligand Drug Conjugates
JP2020517599A (ja) 四級化ニコチンアミドアデニンジヌクレオチドサルベージ経路阻害剤コンジュゲート
CA3099419A1 (en) Tetrazines for high click conjugation yield in vivo and high click release yield
JP7675060B2 (ja) 治療薬としての微小管標的化剤のペプチドコンジュゲート
AU2018368520A1 (en) Ligand-drug-conjugates as substrates for selective cleavage by the exopeptidase activity of Cathepsin B
KR20240119102A (ko) 표적화 접합체의 제조를 위한 친수성 테트라진-관능화 페이로드
EP2836493B1 (en) Functionalized thieno-indole derivatives for the treatment of cancer
CN118215506A (zh) 蒽环类衍生物接头试剂、抗体-药物缀合物及方法
WO2023222019A1 (zh) 配体药物偶联物及其应用
CN118574642A (zh) 作为治疗剂的肽微管蛋白抑制剂的肽缀合物
AU2024316659A1 (en) Drug conjugates and methods of preparing and using the same
IL322216A (en) Drug conjugates, methods for their preparation and use
US20250269050A1 (en) Cyclic dichalcogenide adc linker units and uses thereof
HK40069235A (en) Delivery systems for controlled drug release
WO2024178310A1 (en) Trop2-directed antibody-drug conjugates and uses thereof
EA051761B1 (ru) Пептидные конъюгаты агентов, нацеленных на микротрубочки, в качестве терапевтических средств
HK1254624B (en) Delivery systems for controlled drug release